GE HealthCare Technologies (NASDAQ:GEHC) Shares Down 5.9% – What’s Next?

GE HealthCare Technologies Inc. (NASDAQ:GEHCGet Free Report) was down 5.9% on Tuesday . The company traded as low as $61.43 and last traded at $61.4680. Approximately 1,141,945 shares changed hands during mid-day trading, a decline of 74% from the average session volume of 4,315,394 shares. The stock had previously closed at $65.31.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Rothschild & Co Redburn lowered their target price on GE HealthCare Technologies from $110.00 to $98.00 in a report on Thursday, April 30th. Evercore set a $80.00 price target on GE HealthCare Technologies in a report on Thursday, April 30th. The Goldman Sachs Group reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a research report on Monday, June 8th. Wells Fargo & Company decreased their price objective on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a report on Thursday, April 30th. Finally, BTIG Research reissued a “buy” rating and issued a $75.00 target price on shares of GE HealthCare Technologies in a research report on Monday. Ten research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $79.48.

Check Out Our Latest Analysis on GEHC

GE HealthCare Technologies Stock Performance

The company has a market capitalization of $28.75 billion, a price-to-earnings ratio of 15.12, a P/E/G ratio of 1.68 and a beta of 0.72. The stock’s 50 day moving average price is $63.56 and its 200 day moving average price is $72.15. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same period in the prior year, the firm posted $1.01 EPS. GE HealthCare Technologies’s revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, July 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.35%.

Insider Activity at GE HealthCare Technologies

In other news, CFO James Saccaro bought 3,310 shares of the stock in a transaction that occurred on Friday, May 1st. The shares were acquired at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the completion of the acquisition, the chief financial officer owned 87,471 shares in the company, valued at approximately $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Peter J. Arduini bought 4,169 shares of the stock in a transaction that occurred on Thursday, April 30th. The shares were purchased at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the acquisition, the chief executive officer owned 259,424 shares of the company’s stock, valued at $15,544,686.08. The trade was a 1.63% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have purchased 21,847 shares of company stock worth $1,361,355. Insiders own 0.36% of the company’s stock.

Institutional Investors Weigh In On GE HealthCare Technologies

Institutional investors and hedge funds have recently modified their holdings of the company. Laurel Wealth Advisors LLC bought a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $26,000. Optima Capital LLC acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Godfrey Financial Associates Inc. bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth approximately $27,000. Montag A & Associates Inc. boosted its stake in shares of GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 262 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

About GE HealthCare Technologies

(Get Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Further Reading

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.